Correlation Between Vaccinex and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Monopar Therapeutics, you can compare the effects of market volatilities on Vaccinex and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Monopar Therapeutics.
Diversification Opportunities for Vaccinex and Monopar Therapeutics
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vaccinex and Monopar is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Vaccinex and Monopar Therapeutics
Given the investment horizon of 90 days Vaccinex is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vaccinex is 4.17 times less risky than Monopar Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,310 in Monopar Therapeutics on August 29, 2024 and sell it today you would earn a total of 760.00 from holding Monopar Therapeutics or generate 58.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. Monopar Therapeutics
Performance |
| Timeline |
| Vaccinex |
| Monopar Therapeutics |
Vaccinex and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Monopar Therapeutics
The main advantage of trading using opposite Vaccinex and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |